From: Association of HSD17B13 rs72613567: TA allelic variant with liver disease: review and meta-analysis
Liver disease | Number of studies | Relevance test | Heterogeneity test | Publication | |||||
---|---|---|---|---|---|---|---|---|---|
OR(95% CI) | Z | Pvalue | I2 | Q | Phel | Pegger | |||
HCC compared with CLD (allelic model) | 5 | 0.766(0.682–0.860) | 4.51 | 0.000 | 45.8 | 7.38 | 0.117 | 0.378 | 1.03 |
HCC compared with CLD (additive model) | 3 | 0.755(0.645–0.885) | 3.47 | 0.001 | 0 | 1.91 | 0.384 | 0.845 | -0.25 |
HCC compared with healthy controls (allelic model) | 3 | 0.648(0.429–0.979) | 2.06 | 0.039 | 62.1 | 5.28 | 0.071 | 0.033 | 19.01 |
NAFLD compared with NON-NAFLD (allelic model) | 5 | 0.669(0.524–0.856) | 3.20 | 0.001 | 68.9 | 12.87 | 0.012 | 0.280 | 0.800 |
NAFLD compared with healthy controls (allelic model) | 3 | 0.600(0.464–0.777) | 3.89 | 0.000 | 50.3 | 4.02 | 0.134 | 0.060 | 0.963 |